Food safety and quality
| share
 

OECD Unique Identifier details

DAS-81419-2
Commodity: Soyabean / Soybeans
Traits: Insect resistance
Argentina
Name of product applicant: Dow AgroSciences S.A.
Summary of application:

Soy resistant to certain insect pests Lepidoptera and tolerant to herbicides based on glufosinate ammonium, thanks to the incorporation of the genes cry1Ac and cry1F, from Bacillus thuringiensis and pat, from Streptomyces viridochromogenes.

Upload:
Date of authorization: 14/07/2016
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
• Inheritance studies conducted indicated that Mendelian segregation exists. • New expression proteins are expressed in low levels. • It is compositionally equivalent to its non-transgenic counterpart. • No evidence of similarity or homology was found with known toxic proteins. • There is no evidence of expression of known allergenic substances for the proteins expressed in the event. It is concluded that the event is substantially equivalent to its conventional counterpart, therefore, it is as safe and no less nutritious than conventional commercial varieties.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: GMO commercial approvals in Argentina
GMO approvals for food/feed
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministerio de Agroindustria
Contact person name:
Andrés Maggi
Website:
Physical full address:
Paseo Colón Avenue 367, 3° floor, City of Buenos Aires
Phone number:
54 11 5222 5986
Fax number:
Country introduction:

In Argentina, the food and feed risk assessment process of transformation events, as the result of modern biotechnology, is carried out by the National Service for Agrifood Health and Quality (Senasa). The General Office of Biotechnology, is the area responsible for carrying out this task. It has an specific professional team and the advise of a Technical Advisory Committee composed of experts from several scientific disciplines representing different sectors involved in the production, industrialization, consumption, research and development of genetically modified organisms.

Useful links
Relevant documents
Stacked events:

Stacked events with all single events approved, are assessed as a new event, but with much less requirements, always on a case-by-case basis.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

National Service for Agrifood Health and Quality (Senasa)

https://www.argentina.gob.ar/senasa

 

https://www.argentina.gob.ar/senasa/programas-sanitarios/biotecnologia

Australia
Name of product applicant: Dow AgroSciences Australia Ltd
Summary of application:
A genetically modified (GM) soybean line with OECD Unique Identifier DAS-81419-2, hereafter also referred to as soybean 81419, has been developed that is protected against several lepidopteran pests of soybean, including soybean looper (Chrysodeixis includens, formerly Pseudoplusia includens), velvetbean caterpillar (Anticarsia gemmatalis), fall armyworm (Spodoptera frugiperda) and tobacco budworm (Heliothis virescens).
The line contains two insecticidal genes, cry1Ac(synpro) and cry1Fv3, derived from the common soil bacterium Bacillus thuringiensis (often referred to just as ‘Bt’). The cry1Ac(synpro) gene is a synthetic chimera comprising sequences from: the cry1Ac1 gene originally isolated from B. thuringiensis subsp. kurstaki strain HD73; the cry1Ca3 gene originally isolated from B. thuringiensis subsp. aizawai strain PS811; and the cry1Ab1 gene originally isolated from B. thuringiensis subsp. berliner 1715. Similarly the cry1Fv3 gene is chimeric and comprises sequences from the cry1Fa2 gene originally isolated from Bacillus thuringiensis subsp. aizawai strain PS811; the cry1Ca3 gene originally isolated from B. thuringiensis subsp.aizawai strain PS811; and at the cry1Ab1 gene originally isolated from B. thuringiensis subsp. berliner 1715.
These genes express two insecticidal proteins which, for the purposes of this assessment are referred to as Cry1Ac and Cry1F. These two proteins have the same amino acid sequence as those expressed in WideStrike cotton considered in FSANZ Application A518.
The Applicant claims that the genetic modification will provide growers in a number of countries around the world with improved insect resistance management and an alternative to chemical insecticides. Using two B. thuringiensis-derived insecticidal proteins, rather than one, in the same plant improves the spectrum of control and the seasonal efficacy and significantly reduces the chances of selecting insects resistant to the toxins. Bt formulations are widely used as biopesticides on a variety of cereal and vegetable crops grown organically or under conventional agricultural conditions.
In addition to the two cry genes, soybean 81419 contains a selectable marker gene (pat) from the bacterium Streptomyces viridochromogenes, which produces an enzyme (phosphinothricin acetyltransferase, PAT) that detoxifies the herbicide glufosinate ammonium. PAT functions as a selectable marker in the initial laboratory stages of plant cell selection and thus soybean 81419 is also tolerant to the herbicide glufosinate ammonium. However, the Applicant states it is not intended that this trait be used in commercial production of soybean 81419 and no MRL for glufosinate ammonium is being sought. The pat gene has been widely used for genetic modification of a number of crop species, including soybean.
It is anticipated that soybean 81419 may be grown predominantly in North and South America. The Applicant has not indicated that there is any intention to grow the plant line in Australia or New Zealand.
Upload:
Date of authorization: 15/05/2014
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): OECD BioTrack Product Database
Summary of the safety assessment (food safety):
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: A1087 - Food derived from Insect-protected Soybean Line DAS-81419-2
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food Standards Australia New Zealand
Contact person name:
Website:
Physical full address:
Level 4, 15 Lancaster Place, Majura Park ACT 2609, Australia
Phone number:
+61 2 6271 2222
Fax number:
+61 2 6271 2278
Country introduction:

Food Standards Australia New Zealand (FSANZ) is the regulatory agency responsible for the development of food standards in Australia and New Zealand. The main office (approximately 115 staff) is located in Canberra (in the Australian Capital Territory) and the smaller New Zealand office (approximately 10 staff) is located in Wellington on the North Island.

Useful links
Relevant documents
Stacked events:

FSANZ does not: Separately assess food from stacked event lines where food from the GM parents has already been approved; Mandate notification of stacked events by developers; Notify the public of stacked event ‘approvals’; List food derived from stacked event lines in the Code, unless the stacked event line has been separately assessed as a single line e.g. Application A518: MXB-13 cotton (DAS-21023-5 x DAS-24236-5)

No separate approval or safety assessment is necessary for foods derived from a stacked GM line that is the result of traditional breeding between a number of GM parent lines for which food has already been approved. Food from the parent lines must be listed in the Australia New Zealand Food Standards Code. The parent lines may contain any number of different genes. If food from any of the GM parent lines has not been approved, then a full pre-market safety assessment of food from the stacked line must be undertaken.

No separate approval is required for food derived from a line that is the product of a GM line, for which food has been approved, crossed traditionally with a non-GM line.

Where a single line containing a number of genes has been produced as a result of direct gene technology methods (rather than traditional crossing) then food derived from the line must undergo a full pre-market safety assessment before approval can be given

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Standards Australia New Zealand (FSANZ) (http://www.foodstandards.gov.au)

Brazil
Name of product applicant: Dow Agroscience
Summary of application:

Commercial release of insect resistant soybean and glufosinate ammonium tolerant

Upload:
Date of authorization: 28/12/2016
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
The human and animal food safety of soybean DAS-81419-2 was analyzed through studies of chemical and nutritional composition in root, forage and grains compared to conventional cultivar. The levels of proteins, fibers, minerals, amino acids, vitamins, fatty acids, antinutrients, isoflavonoids, etc. were quantified. The results showed that genetically modified soybean does not differ from conventional soybean in its chemical and nutritional composition, except for the presence and expression of the described genes, as expected. The environmental safety of the event was analyzed in studies carried out in Brazil and in other countries that demonstrated that genetically modified soybean does not differ from conventional soybean in agronomic, morphological and reproductive characteristics, as it is equivalent in chemical and nutritional composition, except for the characteristics Tolerance to glufosinate ammonium and insect resistance. The phenotype of the transformed plants containing the described genes is similar to the original plant phenotype as regards the reproductive organs, the duration of the plant development period, and its propagation method. In addition, soybean containing the said transformation event, like conventional soybeans, does not tend to proliferate as a weed, and is not an invasive species in natural ecosystems.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Molecular traditional methods
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date) Not Applicable
E-mail:
Organization/agency name (Full name):
National Biosafety Technical Commission
Contact person name:
Maria Sueli Felipe Soares
Website:
Physical full address:
SPO Area 5 Qd 3 Bl B S 10.1 Brasilia DF
Phone number:
556134115516
Fax number:
556133177475
Country introduction:

Brazil had the first biosafety law approved in 1995. After the identification of the need to improve the biosafety system of Brazilian genetically modified organisms, a new law was published. The Law 11.105 / 05 establishes a technical committee dedicated to the analysis of the safety aspects of genetically modified organisms and a council of ministers that is dedicated to the analysis of the socioeconomic aspects of the commercial release of genetically modified organisms. In this context, Brazil already has several commercial products that involve genetically modified organisms (plants, human and veterinary vaccines, microorganisms for fuel production) and products derived from new genetic modification techniques.

Useful links
Relevant documents
Stacked events:

At the discretion of, and upon consultation with, CTNBio, a new analysis and issuance of technical opinion may be released on GMOs containing more than one event, combined through classic genetic improvement and which have been previously approved for commercial release by CTNBio

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Dr. Edivaldo Domingues Velini (President of national Biosafety Commission)

Canada
Name of product applicant: Dow AgroSciences Canada Inc.
Summary of application:

Dow AgroSciences Canada Inc. has developed a soybean event that is resistant to lepidopteran insects and tolerant to the herbicide glufosinate-ammonium. Soybean event DAS-81419-2 was developed by Dow AgroSciences Canada Inc.using recombinant deoxyribonucleic acid (DNA) technology, resulting in the introduction of the cry1Accry1F and patgenes. The cry1Ac and cry1F genes are derived from Bacillus thuringiensis and encode insecticidal Cry proteins. The pat gene is derived from the soil bacterium Streptomyces viridochromogenes and encodes a phosphinothricin acetyltransferase (PAT) enzyme. This enzyme inactivates the herbicide glufosinate-ammonium.

Upload:
Date of authorization: 13/11/2014
Scope of authorization: Feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): BioTrack Product Database
Summary of the safety assessment (food safety):
Please see decision document weblink
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Novel Feeds Decision Document
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Health Canada
Contact person name:
Neil Strand
Website:
Physical full address:
251 Sir Frederick Banting Driveway, Tunney's Pasture, PL 2204A1
Phone number:
613-946-1317
Fax number:
Country introduction:

Federal responsibility for the regulations dealing with foods sold in Canada, including novel foods, is shared by Health Canada and the Canadian Food Inspection Agency (CFIA). Health Canada is responsible for establishing standards and policies governing the safety and nutritional quality of foods and developing labelling policies related to health and nutrition. The CFIA develops standards related to the packaging, labelling and advertising of foods, and handles all inspection and enforcement duties. The CFIA also has responsibility for the regulation of seeds, veterinary biologics, fertilizers and livestock feeds. More specifically, CFIA is responsible for the regulations and guidelines dealing with cultivating plants with novel traits and dealing with livestock feeds and for conducting the respective safety assessments, whereas Health Canada is responsible for the regulations and guidelines pertaining to novel foods and for conducting safety assessments of novel foods.

The mechanism by which Health Canada controls the sale of novel foods in Canada is the mandatory pre-market notification requirement as set out in Division 28 of Part B of the Food and Drug Regulations.

Manufacturers or importers are required under these regulations to submit information to Health Canada regarding the product in question so that a determination can be made with respect to the product's safety prior to sale. The safety criteria for the assessment of novel foods outlined in the current guidance document (i.e. Canadian Guidelines for the Safety Assessment of Novel Foods) were derived from internationally established scientific principles and guidelines developed through the work of the Organization for Economic Cooperation and Development (OECD), Food and Agriculture Organisation (FAO), World Health Organisation (WHO) and the Codex Alimentarius Commission. These guidelines provide for both the rigour and the flexibility required to determine the need for notification and to conduct the safety assessment of the broad range of food products being developed. This flexibility is needed to allow novel foods and food products to be assessed on a case-by-case basis and to take into consideration future scientific advances.

Useful links
Relevant documents
Stacked events:

Food: Consistent with the definition of "novel food" in Division 28 of the Food and Drug Regulations, the progeny derived from the conventional breeding of approved genetically modified plants (one or both parents are genetically modified) would not be classified as a novel food unless some form of novelty was introduced into such progeny as a result of the cross, hence triggering the requirement for pre-market notification under Division 28. For example, notification may be required for modifications observed in the progeny that result in a change of existing characteristics of the plant that places those characteristics outside of the accepted range, or, that introduce new characteristics not previously observed in that plant (e.g. a major change has occurred in the expression levels of traits when stacked). In addition, the use of a wild species (interspecific cross) not having a history of safe use in the food supply in the development of a new plant line may also require notification to Health Canada. However, molecular stacks are considered new events and are considered to be notifiable as per Division 28.

Feed:

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Neil Strand, Section Head of Novel Foods

Colombia
Name of product applicant: Dow Agrosciences Colombia S.A
Summary of application:

Authorization of the genetically modified soy DAS81419 resistant to lepidoptera pest attack

Upload:
Date of authorization: 28/11/2016
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Based on the risk assessment, it can be concluded that the event shows the same risks as its conventional counterpart. Therefore the National Technical Biosafety Committee for GMO use exclusively in Health and human consumption (CTNSalud) recommends its authorization.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministerio de salud y proteccion social
Contact person name:
Daniel Rubio
Website:
Physical full address:
Carrera 13 No. 32- 76 piso 12, Bogotá
Phone number:
330 5000 ext 1256
Fax number:
Country introduction:

The 4525 decree of 2005, established the Ministry of Health and Social Protection as the competent authority for GMO for health and food purposes and creates the National Biosafety Technical Committee for GMO's used in health and food purposes (CTNSalud).

The CTNSalud is composed by the Ministry of Health and Social Protection, the National Food and Drug Surveillance Institute (INVIMA) and the Technology and Innovation Administrative Department (COLCIENCIAS). This committee is responsible for the assesment of risk assessments; to inquire for any additional information; assessment of any measurements in accordance to the Cartagena Protocol; and the recommendation for the authorization of GMO for health or food purposes.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Japan
Name of product applicant: Dow Chemical JapanLtd.
Summary of application:

Soy line DAS-81419-2 was transformed with the insertion of Cry1F and Cry1Ac to confer resistance to lepidopteran insects as well as the insertion of the pat gene which results in the synthesis of phosphinothricin N-acetyltransferase thus coffering tolerance to glufosinate herbicides.

Upload:
Date of authorization: 26/12/2014
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): BCH Database
Summary of the safety assessment (food safety):
Please see the link below.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Food safety assessment performed by Food Safety Commission of Japan
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food Safety Commission Secretariat,Cabinet Office,
Contact person name:
Mariko Murakami
Website:
Physical full address:
Akasaka 5-2-20 Minato Ward,Tokyo,Japan
Phone number:
81 3 6234 1122
Fax number:
81 3 3584 7392
Country introduction:
Safety assessments of GM foods are mandatory under the Food Sanitation Law in Japan. The Ministry of Health, Labour, and Welfare (MHLW) legally imposes safety assessments of GM foods so that those that have not undergone safety assessments would not be distributed in the country. MHLW receives application and requests the Food Safety COmmission of Japan (FSCJ) to evaluate the safety of GM foods in terms of human health. Safety assessments are carried out by FSCJ.
Useful links
Relevant documents
Stacked events:

With regard to stacked events, FSCJ conducts the safety assessment of GM food based on the “Policies Regarding the Safety Assessment of Stacked Varieties of Genetically Modified Plants”.

Even if single events that are stacked have already approved, some products will be considered as new products and some will not.

Please refer to Article 5 and 6 of the MHLW’s notice, which is available at the following URL, for the details.

http://www.mhlw.go.jp/file/06-Seisakujouhou-11130500-Shokuhinanzenbu/0000053519.pdf

Article 6 was modified in 2014, and the modified version is available at the following URL.

http://www.mhlw.go.jp/file/06-Seisakujouhou-11130500-Shokuhinanzenbu/0000049695.pdf

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Safety Commission of Japan (http://www.fsc.go.jp/english/index.html), Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/policy/health-medical/food/index.html)

Malaysia
Name of product applicant: DOW AGROSCIENCES (MALAYSIA) SDN. BHD.
Summary of application:

Please refer to the decision document of the National Biosafety Board

Upload:
Date of authorization: 19/10/2017
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): Malaysia Biosafety Clearing House
CBD Biosafety Clearing House
Summary of the safety assessment (food safety):
Please refer to the Risk Assessment Report
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Department of Biosafety Malaysia
Contact person name:
Dr. Anita Anthonysamy
Website:
Physical full address:
Department of Biosafety Ministry of Environment and Water Level 4, Block F11, Complex F Lebuh Perdana Timur, Precinct 1 62000 Putrajaya, Malaysia
Phone number:
+60388861153
Fax number:
+60388904935
Country introduction:

GM food safety assessment is a requirement by law under the Biosafety Act 2007 in Malaysia. The National Biosafety Board reviews and makes decisions on events based on a scientific/technical risk assessment, policy considerations as well as public input. The decisions and its related documents made are publicly available through the Malaysian Department of Biosafety Website and the Convention of Biological Diversity Biosafety Clearing House.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Department of Biosafety Malaysia, Level 1, Podium 2, Wisma Sumber Asli No. 25, Persiaran Perdana, Precinct 4 Putrajaya, Federal Territory Malaysia, 62574. Phone: +603 8886 1746 / 1579. Fax: +603-8889 5604 Email: [email protected] Url: www. biosafety.gov.my

 

Food Safety and Quality Division, Ministry of Health, Level 4, Menara Prisma, No. 26, Persiaran Perdana, Putrajaya, Malaysia, 62675. Phone: +603 88850797 Fax: +603 88850790 Email: [email protected]
Mexico
Name of product applicant: Dow AgroSciences, S.A. de C.V.
Summary of application:

Authorization by COFEPRIS: 137


Soy line DAS-81419-2 was transformed with the insertion of Cry1F and Cry1Ac to confer resistance to lepidopteran insects as well as the insertion of the pat gene which results in the synthesis of phosphinothricin N-acetyltransferase thus coffering tolerance to glufosinate herbicides.

Upload:
Date of authorization: 24/02/2015
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
UI OECD: DAS-81419-2 During the risk assessment of this GMO based on existing knowledge to date, no toxic or allergic effects neither substantial nutritional changes are observed. The event is as safe as its conventional counterpart. For more detail please find attached the risk assessment summary in this page.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
CIBIOGEM
Contact person name:
Biól. Erica L. Hagman Aguilar
Website:
Physical full address:
San Borja #938, Col. Del Valle • Del. Benito Juárez C.P. 03100, México, D.F.
Phone number:
+52 (55) 53227700
Fax number:
Country introduction:

México ha buscado garantizar la inocuidad de los productos biotecnológicos para el uso y consumo de su población. Desde 1984 el artículo 282 bis 1 de la Ley General de Salud, contempló que la Secretaría de Salud debería regular aquellos productos biotecnológicos, o sus derivados, destinados al uso o consumo humano. En un inicio, con fundamento en este artículo, la Secretaria de Salud evaluó la inocuidad alimentaria de productos biotecnológicos, para su comercialización con fines de uso o consumo humano. A partir de 2005, con la entrada en vigor de la Ley de Bioseguridad de Organismos Genéticamente Modificados (LBOGM), se realizó la adecuación de la regulación para dar lugar a la Autorización que es el acto administrativo mediante el cual la Secretaría de Salud, a través de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), autoriza Organismos Genéticamente Modificados (OGMs), a efecto de que se pueda realizar su comercialización, así como su utilización con finalidades de Salud Pública o de Biorremediación.

Las facultades que corresponden a la Secretaría de Salud se estipulan en el artículo 16 de la LBOGM y lo relativo a la Autorizaciones se describe en los artículos 91 al 98 de dicha Ley. Quienes pretendan obtener una Autorización para Comercialización e Importación de OGMs deben presentar ante COFEPRIS, una solicitud por escrito acompañada de la información a que se refiere los artículos 23 al 32 del Reglamento de la Ley de Bioseguridad de OGMs.

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/LBOGM.pdf

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/Reg_LBOGM.pdf

 

Courtesy translation

Mexico has sought to guarantee the safety of biotechnological products the use and consumption of its population. Since 1984, article 282 bis 1 from the General Law of Health, considered that the Secretary of Health should regulate those biotechnological products, or their derivatives, intended for food and feed use. Initially, the Secretary of Health evaluated the food safety of biotechnological products, based on this article, for commercialization with purposes of food, feed and processing. Subsequently in 2005, with the entry into force of the Law on Biosafety of Genetically Modified Organisms (LBOGM), the regulation was adapted to give rise to the Authorization, which is the administrative act through which the Secretary of Health, by means of the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS), authorizes Genetically Modified Organisms (GMOs), to their commercialization, as well as their use for purposes of public health or bioremediation.

The faculties that correspond to the Secretary of Health are stipulated in Article 16 of the LBOGM and what is related to the Authorizations is described in Articles 91 to 98 of this Law. Those who seek to obtain an Authorization for GMOs merchandising and importation, must present to COFEPRIS, a written request accompanied by the information referred into articles 23 to 32 of the Regulation of the Law on Biosafety of Genetically Modified Organisms.

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/LBOGM.pdf

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/Reg_LBOGM.pdf

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Secretaría de Salud / Phone: +52 55 5080 5200 /Email: [email protected]%20

New Zealand
Name of product applicant: Dow AgroSciences Australia Ltd
Summary of application:

A genetically modified (GM) soybean line with OECD Unique Identifier DAS-81419-2, hereafter also referred to as soybean 81419, has been developed that is protected against several lepidopteran pests of soybean, including soybean looper (Chrysodeixis includens, formerly Pseudoplusia includens), velvetbean caterpillar (Anticarsia gemmatalis), fall armyworm (Spodoptera frugiperda) and tobacco budworm (Heliothis virescens). 
The line contains two insecticidal genes, cry1Ac(synpro) and cry1Fv3, derived from the common soil bacterium Bacillus thuringiensis (often referred to just as ‘Bt’). The cry1Ac(synpro) gene is a synthetic chimera comprising sequences from: the cry1Ac1 gene originally isolated from B. thuringiensis subsp. kurstaki strain HD73; the cry1Ca3 gene originally isolated from B. thuringiensis subsp. aizawai strain PS811; and the cry1Ab1 gene originally isolated from B. thuringiensis subsp. berliner 1715. Similarly the cry1Fv3 gene is chimeric and comprises sequences from the cry1Fa2 gene originally isolated from Bacillus thuringiensis subsp. aizawai strain PS811; the cry1Ca3 gene originally isolated from B. thuringiensis subsp.aizawai strain PS811; and at the cry1Ab1 gene originally isolated from B. thuringiensis subsp. berliner 1715. 
These genes express two insecticidal proteins which, for the purposes of this assessment are referred to as Cry1Ac and Cry1F. These two proteins have the same amino acid sequence as those expressed in WideStrike cotton considered in FSANZ Application A518. 
The Applicant claims that the genetic modification will provide growers in a number of countries around the world with improved insect resistance management and an alternative to chemical insecticides. Using two B. thuringiensis-derived insecticidal proteins, rather than one, in the same plant improves the spectrum of control and the seasonal efficacy and significantly reduces the chances of selecting insects resistant to the toxins. Bt formulations are widely used as biopesticides on a variety of cereal and vegetable crops grown organically or under conventional agricultural conditions. 
In addition to the two cry genes, soybean 81419 contains a selectable marker gene (pat) from the bacterium Streptomyces viridochromogenes, which produces an enzyme (phosphinothricin acetyltransferase, PAT) that detoxifies the herbicide glufosinate ammonium. PAT functions as a selectable marker in the initial laboratory stages of plant cell selection and thus soybean 81419 is also tolerant to the herbicide glufosinate ammonium. However, the Applicant states it is not intended that this trait be used in commercial production of soybean 81419 and no MRL for glufosinate ammonium is being sought. The pat gene has been widely used for genetic modification of a number of crop species, including soybean. 
It is anticipated that soybean 81419 may be grown predominantly in North and South America. The Applicant has not indicated that there is any intention to grow the plant line in Australia or New Zealand.

Upload:
Date of authorization: 07/08/2014
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): OECD BioTrack Product Database
Summary of the safety assessment (food safety):
In conducting a safety assessment of food derived from soybean line DAS-81419-2, a number of criteria have been addressed including: a characterisation of the transferred gene and its origin, function and stability in the soybean genome; the changes at the level of DNA, protein and in the whole food; compositional analyses; evaluation of intended and unintended changes; and the potential for the newly expressed proteins to be either allergenic or toxic in humans. On the basis of the data provided in the present Application, and other available information, food derived from soybean line DAS-81419-2 is considered to be as safe for human consumption as food derived from conventional soybean cultivars.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: A1087 – Food derived from Insect-protected Soybean Line DAS-81419-2
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministry for Primary Industries
Contact person name:
Fiapaipai Auapaau
Website:
Physical full address:
Pastoral House, 25 The Terrace, Wellington, 6012
Phone number:
+6448314946
Fax number:
Country introduction:

New Zealand and Australia share a joint food regulation system for the composition of labelling of most foods. Food Standards Australia New Zealand (FSANZ) is the regulatory agency responsible for the development of the joint food standards in Australia and New Zealand. The main office (approximately 120 staff) is located in Canberra (in the Australian Capital Territory) and the smaller New Zealand office (approximately 15 staff) is located in Wellington on the North Island.

Useful links
Relevant documents
Stacked events:

FSANZ does not: Separately assess food from stacked event lines where food from the GM parents has already been approved; Mandate notification of stacked events by developers; Notify the public of stacked event ‘approvals’; List food derived from stacked event lines in the Code, unless the stacked event line has been separately assessed as a single line e.g. Application A518: MXB-13 cotton (DAS-21023-5 x DAS-24236-5)

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Standards Australia New Zealand (FSANZ) (http://www.foodstandards.gov.au)

Philippines
Name of product applicant: Dow AgroSciences
Summary of application:

On January 20, 2017, Dow AgroSciences BV Philippine Branch submitted soybean DAS 81419-2 for direct use as food and feed, or for processing, as original application under the DOST-DA-DENR-DOH-DILG Joint Department Circular (JDC) No. 1 Series of 2016.


 


After reviewing the Risk Assessment Report and attachments submitted by the applicant, the assessors namely: Scientific and Technical Review Panel (STRP), BPI Plant Products Safety Services Division (BPI-PPSSD) and Bureau of Animal Industry- Biotech Team (BAI-BT), concurred that soybean DAS 81419-2 is as safe for human food and animal feed as its conventional counterpart.

Upload:
Date of authorization: 07/05/2019
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
STRP ASSESSMENT AND RECOMMENDATIONS Based on the documents submitted by the applicant: A. Host Organism Soybean is the main source of key nutrients in feed/food of monogastric animals; especially important are the essential amino acids and the unsaturated fatty acids necessary for growth, development and maintenance of the body. It also contains antinutrients which are heat-inactivated during processing (soybean is not consumed raw by humans) While NO is given as an answer for presence of toxicants, it should be noted that in Toxicology, “Only the dose determines the toxicity. An example of this is selenium which is listed in Table 20. Composition Analytes on page 129 of 174.Selenium serves as an antioxidant at low levels but could also be toxic when taken at high dosage. Food allergens have also been noted in soybean which may cause IgE-mediated reaction. Data on the use of the consumed food products, both raw and processed soybean have been adequately provided. Countries that use the transgenic soybean plant as food were enumerated: these are the US, Australia, and New Zealand. An adequate list of use of soybean for feed is also given. Data was provided on countries having the highest consumption of soybean foods (Thailand, immature seeds; Japan, dry beans; USA, soybean oil) and the consumption of the general population and children in particular. The data was based on global data published by the World Health Organization B. Donor Organism All potentially inserted protein encoding (or antisense) sequences have been described adequately with respect to source and potential pathogenic and allergenic properties. Source organisms of the regulatory proteins were described. These are Arabidopsis thaliana, Agrobacterium tumefaciens and Cassava vein mosaic virus. Functions of these regulatory elements were described, including their placement in the T-DNA insert and plasmid. No reported pathogenicity or allergenicity of Cry1Ac, Cry1F and PAT. C. Transformation System The transgenic soybean was generated through Agrobacterium-mediated transformation of soybean cotyledonary node explants. The step by step procedure used was thoroughly presented. The target of genetic modification was the nuclear DNA. This was thoroughly and adequately presented and complete experimental protocol was provided. Table of genetic elements of the T-DNA insert and plasmid pDAB9582 was given together with names of elements, position in the plasmid, length of gene and description of the genetic element. No carrier DNA was used for the transformation of pDAB9582 into soybean Glycine max. The Agrobacterium tumefaciens strain EMA 101 carries the helper plasmid, pT1Bo 542. EMA 101 was generated by the inactivation of the T-DNA One genes in strain A281(Hood et al.,1986). D. Inserted DNA All data obtained indicate that there is a single insertion of the T-DNA containing all the expected elements from pDAB9582 in DAS-81419-2 soybean genome. This site was demonstrated by Southern Blot Analysis. Results showed that the transgenic insert in DAS-81419-2 soybean occurred as a single integration of the T-DNA insert. The step by step procedure sufficiently demonstrated and confirmed that this transgenic soybean contains a single insertion of the TDNA from pDAB9582. Southern blot analysis of restricted DNA of DAS-81419-2 probed with 6 probes specific for backbone sequences showed absence of plasmid backbone in DAS-81419-2. E. Genetic Stability Southern Blot Analysis confirmed that the DAS-81419-2 soybean contains a single insertion of the T-DNA from pDAB9582. Identical hybridization patterns were observed across 5 distinct generations of DAS-81419-2 soybean, indicating stable inheritance of the transgene insert across multiple generations. This was clearly demonstrated. Segregation analysis of F2 and BC1F2 (segregating) populations on individual plants showed the Mendelian inheritance ration (3:1) for a single independent insert. F. Expressed Material The Cry1Ac in DAS-81419-2 soybean were measured in plant tissue samples which include the leaf, grain, root and forage. The Cry1Ac is mainly found in the leaves.The Cry1Ac protein concentrations expressed by the different parts of the plant were measured using ELISA (enzyme-linked immunosorbent assay). ELISA is a very sensitive (meaning, could detect very minute amounts like ng/mg) and thus, appropriate method of measure. The Cry1F protein concentrations expressed by the different parts of the plant were likewise measured using ELISA.The Cry1F concentrations as measured using ELISA showed high amounts in the leaves. ELISA was also used to measure the PAT contents of the plant tissues. PAT was found to be high in the leaves and the forage. G. Toxicological Assessment Cry1Ac protein was readily degraded in SGF in <1min. This protein digestion is very fast. Result showed that there were no large size fragments that remained after <1 minute exposure to SGF. Cry1Ac protein was also found to be denatured readily by heat (<1minute) and="" lost="" its="" immunoreactivity="" cry1ac="" protein="">99% of its immunoreactivity with results showing that it was almost undetectable by ELISA after exposure to heat treatment. This isa very clear demonstration of how fast heat affects this protein. Amino Acid Comparison of Cry1Ac with toxin homology was carried out. Amino acid homologies with the Cry1Ac protein sequence were evaluated using BLASTp search algorithm against the GenBank non-redundant data set. None of the proteins returned by the BLASTp search are associated with protein toxins that are harmful to humans or animals. Results showed that Cry1Ac protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins. Oral toxicity studies were performed in mice. At the end of the two-week observation period, all mice survived and no gross pathological lesions were noted in any animalused in thestudy. Under the conditions of this study, the acute oral LD50 of Cry1Ac was greater than the 700mg/lg dose given.In livestock, adequate margin of safety have been noted (>2000mg/kg). Data from molecular weight, response to specific antibodies, and peptide mass fingerprinting showed equivalency of Cry1Ac in soybean DAS 81419-2 to Pseudomonas fluorescens. Meanwhile, the digestibility test of Cry1F was done using the Simulated Gastric Fluid (SGF). Digestibility of microbial Cry1F protein, equivalent to Cry1F protein expressed in DAS-81419-2 soybean was tested in vitro using the simulated gastric fluid. Digestion of Cry1F protein was noted to be <1 min. This experiment shows the very fast degradation ofCry1F protein. No large size fragments remained after digesting in SGF for various periods of time. In fact, the Cry1F protein was readily digested in <1 minute. The Cry1F protein was also readily denatured and lost its immunoreactivity properties. Results showed that it was almost undetectable by ELISA after exposure to the heat treatment. Amino Acid Comparison of Cry1F with toxin homology was carried out. Amino acid homologies with Cry1F protein sequence were evaluated using BLASTp search algorithm against the GenBank non-redundant protein dataset. Results of the search showed that the Cry1F protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans or animals. Acute Oral Gavage test was done in mice. At the end of the two-week observation period, no treatment-related clinical signs were noted. No gross pathologic lesions were observed in any of the animals used. The acute oral LD50 of Cry1F protein was reportedly greater than 600mg/kg (dosage given in this study). Data from previous experiments/studies has shown that PAT protein is rapidly degraded in SGF, and by heat. Safety of PAT has been repeatedly demonstrated. Results also showed that PAT protein was readily denatured by heat. ELISA was used to determine the protein denaturation of PAT. PAT protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans/animals. Homologies of protein sequences were evaluated using BLASTp search algorithm against the GenBank non-redundant data set.No homologies were found Acute oral gavage studies on PAT protein have been carried out. Yes, oral gavage studies of PAT protein was done in mice. There was no evidence of acute toxicity in mice at a dose of 5000mg PAT protein/kg body weight. A dietary exposure assessment reveals large margins of exposure (MOE) values for PAT protein in DAS-81419-2 soybean, indicating no concern for adverse effects from protein in soybean based on the available safety threshold information. H. Allergenicity Assessment Cry1Ac protein was readily degraded in SGF in <1min. This protein digestion is very fast. Result showed that there were no large size fragments that remained after <1 minute exposure to SGF. Cry1Ac protein was also found to be denatured readily by heat (<1minute) and="" lost="" its="" immunoreactivity="" cry1ac="" protein="">99% of its immunoreactivity with results showing that it was almost undetectable by ELISA after exposure to heat treatment. This isa very clear demonstration of how fast heat affects this protein. Amino Acid Comparison of Cry1Ac with toxin homology was carried out. Amino acid homologies with the Cry1Ac protein sequence were evaluated using BLASTp search algorithm against the GenBank non-redundant data set. None of the proteins returned by the BLASTp search are associated with protein toxins that are harmful to humans or animals. Results showed that Cry1Ac protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins. Meanwhile, the digestibility test of Cry1F was done using the Simulated Gastric Fluid (SGF). Digestibility of microbial Cry1F protein, equivalent to Cry1F protein expressed in DAS-81419-2 soybean was tested in vitro using the simulated gastric fluid. Digestion of Cry1F protein was noted to be <1 min. This experiment shows the very fast degradation ofCry1F protein. No large size fragments remained after digesting in SGF for various periods of time. In fact, the Cry1F protein was readily digested in <1 minute. The Cry1F protein was also readily denatured and lost its immunoreactivity properties. Results showed that it was almost undetectable by ELISA after exposure to the heat treatment. Amino Acid Comparison of Cry1F with toxin homology was carried out. Amino acid homologies with Cry1F protein sequence were evaluated using BLASTp search algorithm against the GenBank non-redundant protein dataset. Results of the search showed that the Cry1F protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans or animals. Data from previous experiments/studies has shown that PAT protein is rapidly degraded in SGF, and by heat. Safety of PAT has been repeatedly demonstrated. Results also showed that PAT protein was readily denatured by heat. ELISA was used to determine the protein denaturation of PAT. PAT protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans/animals. Homologies of protein sequences were evaluated using BLASTp search algorithm against the GenBank non-redundant data set.No homologies were found I. Nutritional Data There were no significant differences noted when comparison with SE comparator was done. Results from this study demonstrate compositional equivalence between event DAS-81419-2 soybean and non-transgenic soybean. There were no statistical differences noted and, thus, not biologically relevant. 16:0 palmitic, 18:3 linolenic, and 20:1 eicosenoic were shown to significantly differ in DAS 81419-2 and the nontransgenic control. However the values for both DAS 81419-2 and the nontransgenic control was were within literature ranges and/or within the range of the reference/commercial varieties. Statistical analysis was not performed on some fatty acids because greater than 50% of the samples were found to be below the limit of quantification (LOQ). Some differenceswere significant (in 16:0 palmitic, 18:3 linolenic, and 20:1 eicosenoic), however, these werevery small relative to natural variation and, thus,not biologically meaningful as all results are within literature ranges and within the range of the reference varieties included in this study. Lectin composition of DAS 81419-2, nontransgenic control, and reference varieties did not differ significantly. Data shows that the varieties tested did not differ in raffinose concentration, stachyose concentration, TRYPSIN inhibitor concentrations, DAIDZEN levels, GENISTEIN levels hence no need for processing studies. Glycitein values fell within the range as published in the literature, and those obtained for the reference/commercial varieties used in the study. J. Recommendation Find scientific evidence that the regulated article applied for human food and animal feed use is as safe as its conventional counterpart and shall not pose any significant risk to human and animal health BPI-PPSSD ASSESSMENT AND RECOMMENDATION Soybean DAS-81419-2 was developed by Dow AgroSciences B.V., through the use of recombinant DNA technology. The said event was developed through Agrobacterium–mediated transformation of soybean cells with pDAB9582 plasmid vector carrying the pat gene that encodes PAT protein which confers tolerance to glufosinate ammonium-containing herbicides, the cry1Ac gene that encodes Cry1Ac protein and cry1Fv3 gene that encodes Cry1F protein. Both Cry proteins provide resistance against certain lepidopteran insects. Host Organism (Glycine max L.) Soybean (Glycine max L.) has been grown world-wide as an important staple food for humans and feed ingredient for animals. Its major products are seeds, oil, and meal. Unprocessed soybeans are not suitable for food and their use for animal feed remains limited because they contain anti nutritional factors such as trypsin inhibitors and lectins which are inactivated by heat processing. Humans consume soybean mostly in processed form such as soy milk, milk curd/ tofu, whole cooked seed, edible soy oil, soy protein concentrate, isolated soy protein, hydrolyzed vegetable protein, textured soy protein and soy protein fibers. It is also being consumed by animals in the form of seed, forage/silage, hay, meal and hulls (OECD, 2012). Soybean is a source of key nutrients such as proteins, fat, ash, acid detergent fiber (ADF), neutral detergent fiber (NDF), total dietary fiber (TDF), crude fiber, carbohydrates, amino acids, fatty acids, minerals and vitamins (OECD, 2012). Anti-nutrients such as stachyose, raffinose, oligosaccharides, trypsin inhibitors, lectins and phytic acid (ILSI, 2010). History of safe use was attributed to soybean. Based on OECD report, soybeans are commonly consumed in processed form and primary source of oil and protein. Heat processing eliminates the anti-nutritional factors in soybean. Toxicants are not commonly found in soybean. Transgenic Plant DAS-81419-2 soybean has been reviewed and approved for food and/or feed use in many countries including United States (Food and Feed, 2014), Canada (Food and Feed, 2014), Australia & New Zealand (Food and Feed, 2014), Argentina (Food and Feed, 2016), Brazil (Food and Feed, 2016), Colombia (Food and Feed, 2016), Japan (Food and Feed, 2014), Korea (Food and Feed, 2016), Mexico (Food and Feed, 2015), South Africa (Food and Feed, 2016), Taiwan (Food and Feed, 2015) (ISAAA, 2017). Based on the documents provided by the developer, the consumption patterns by population subgroups are not expected to be altered. Donor Organisms Bacillus thuringiensis is a donor of cry1Ac and cry1F genes. Streptomyces viridochromogenes is a donor organism of pat gene. Donor organisms of genetic elements including promoters, terminators and border sequences include Arabidopsis thaliana, Agrobacterium tumefaciens, and Cassava vein mosaic virus. All donor organisms are not known to be toxic and allergenic and has been used in Agrobacterium-mediated transformation of several genetically modified crops. History of safe use was attributed to all donor organisms. Transformation System The event, DAS-81419-2 was developed to express Cry1Ac and Cry1F protein derived from Bacillus thuringiensis and PAT protein derived from Streptomyces viridochromogenes. The transformation method is through Agrobacterium-mediated transformation with plasmid vector pDAB9582. The plasmid vector, is composed of the gene expression cassettes for cry1Ac, cry1F and pat (DAS, 2016). The cry1F v3 gene expression cassette is composed of matrix attachment region (RB7MAR) from Nicotiana tabacum, Arabidopsis thaliana polyubiquitin UBQ10 comprising the promoter, 5’ untranslated region and intron, cry1F v3 gene from Bacillus thuringiensis subspecies aizawai strain PS811, 3’ untranslated region comprising the transcriptional terminator and polyadenylation site of open reading frame 23 of Agrobacterium tumefaciens pTi15955 and intervening sequences (DAS, 2016). The Cry1Ac gene expression cassette is composed of CsVMV promoter along with 5’ untranslated region derived from Cassava Vein Mosaic Virus, cry1Ac gene from Bacillus thuringiensis subspecies kurstaki strain HD73, 3’ untranslated region comprising the transcriptional terminator and polyadenylation site open reading frame 23 of Agrobacterium tumefaciens pTi15955, and intervening sequences (DAS, 2016). The pat gene expression cassette is composed of CsVMV promoter along with 5’ untranslated region derived from Cassava Vein Mosaic Virus, pat gene from Streptomyces viridochromogenes, 3’ untranslated region comprising the transcriptional terminator and polyadenylation site open reading frame 23 of Agrobacterium tumefaciens pTi15955, and intervening sequences (DAS, 2016). Inserted DNA Southern Blot Analyses demonstrated that DAS-81419-2 soybean contains one intact copy of the T-DNA insert at a single locus (DAS, 2016). The integrity and order of genetic elements were demonstrated through southern blot analyses using different probes listed in Table 3, Section 6.1. (DAS, 2016). A minor (<100 bp) fragment of the cry1Ac (synpro) gene was identified at the 5′ end of the T-DNA insert. There were also deletion of 57-bp observed at the site of T-DNA insertion. This was demonstrated through the analysis of the T-DNA insert sequence, border sequence, and parental locus sequence. Bioinformatics analyses indicated that all putative reading frames did not have sequence similarity with known toxins and allergens. Southern blot analysis of NcoI and SphI-digested genomic DNA from DAS-81419-2 showed no plasmid backbone sequences present in DAS-81419-2 (DAS, 2016) Genetic Stability The stability of the T-DNA insert across five generations (T1, T2, T3, T4 and F2) was demonstrated by Southern blot analysis. Results of analysis indicated that the observed fragments were consistent with the expected fragments. This indicates that the inserted genes are stably integrated and inherited from one generation to another (DAS, 2016). Segregation was assessed using both bioassay and event-specific PCR. One population of F2 and three populations of BC1F2 were assessed. Segregation result is consistent with the reported one copy T-DNA insert. Using the Chi-Square Goodness of Fit Test the segregation pattern was determined. The T-DNA insert displayed the expected Mendelian 3:1 segregation pattern for a single independent insert/locus in segregating generations (F2 and BC1F2) (DAS, 2016). Expressed Material Cry1 proteins has specific mode of action on target lepidopteran insects. The protein have no metabolic role in plants (DAS, 2016). PAT protein is involved in the acetylation of L-phosphinothricin, the active isomer of the glufosinate-ammonium herbicide, resulting in tolerance of transgenic plants to post-emergent application of the non-selective herbicide (Herouet et al., 2005). The expression of novel protein in different plant parts is measured using ELISA methods. The measurements are in dry weight basis (ng/mg dry weight) (DAS, 2016). The expression level of Cry1Ac, Cry1F and PAT in grain is 10.41 – 16.95 ng/mg dry weight, 0.79 – 1.40 ng/mg dry weight and 0.63 – 1.12 ng/mg dry weight, respectively. Toxicological and Allergenicity Assessment The safety assessment of novel proteins, CryAc, Cry1F and PAT, includes digestibility, heat inactivation, oral toxicity and amino acid sequence comparison studies to determine its potential to cause toxicity or allergenicity to humans (DAS, 2016). Digestibility study using Simulated Gastric Fluid (SGF) with pepsin demonstrated that Cry1Ac and Cry1F are readily degraded within 1 minute of incubation with SGF, respectively, in presence of pepsin at pH 1.2, a characteristic of most non-toxic proteins (DAS, 2016). According to Hérouet et al., (2005). PAT protein digestibility was tested in simulated gastric fluid containing pepsin and was readily degraded with no large size fragments remaining (OECD, 1999). Heat stability of Cry1Ac and Cry1F protein was determined through SDS-PAGE analysis of the proteins heated at different temperatures (4 and 91⁰C). Polyclonal antibody based Cry1Ac and Cry1F ELISA was used to determine protein immunoreactivity. Cry1Ac and Cry1F protein is immunochemically denatured when heated. The Cry1Ac and Cry1F protein lost greater than 99% and 98% of its immunoreactivity, respectively, with results showing that it was almost undetectable by ELISA after exposure to the heat treatment (Shan and Embrey, 2005). PAT protein is rapidly denatured by heat. This was verified in OECD Consensus Document (1999). BLASTp search algorithm against the GenBank non-redundant protein database showed that PAT has no biologically relevant identities to toxic proteins (DAS, 2016). Amino acid sequence comparison of Cry1Ac, Cry1F and PAT protein to toxins and allergens was conducted using BLASTp search algorithm against the GenBank and FASTA program (DAS, 2016). Bioinformatics tools and comparison to FARRP Allergen Database Version 12 indicates that Cry1Ac, Cry1F and PAT has no amino acid sequence similarity to known allergens (DAS, 2016). Acute oral toxicity study in mice using microbially produced Cry1Ac (700mg/kg body weight) and Cry1F (600mg/kg body weight) indicated that he administration of Cry1Ac and Cry1F did not significantly affect the body weight of mice. There were no gross pathologic lesions observed for any test animals in the study (DAS, 2016). The NOEL for Cry1Ac and Cry1F is 700 and 600 mg/kg body weight, respectively. PAT protein showed no treatment related toxic effects to mice. This was verified in OECD Consensus Document (1999). NOEL for PAT protein is 5000 mg/kg body weight (OECD, 1999). The source of test protein was Pseudomonas fluorescens for the Cry proteins and Escherichia coli for PAT protein. Characterization methods include that it is biochemically and functionally equivalent to Cry1F, Cry1Ac and PAT expressed in DAS-81419-2 soybean (DAS, 2016). The novel proteins are expressed independently of each other. Cry1Ac and PAT proteins are regulated by the same promoter (CsVMV) and therefore are expressed together. Cry1F expression is independent of Cry1Ac and PAT proteins (DAS, 2016). The percent of total protein of Cry1Ac, Cry1F and PAT is estimated to be 0.000003%, 0.00004% and <0.000002%, respectively. IgE binding to extracts of DAS-81419-2 soybean and its non-transgenic control were evaluated with one dimensional (ID) IgE immunoblot and ELISA inhibition using sera from 10-clinically soy allergic patients (DAS, 2016). Results showed that the genetic modification of soybean to produce DAS-81419-2 did not alter endogenous allergens present in conventional soybean. Results of the toxicological and allergenicity assessment indicate that Cry1Ac, Cry1F and PAT proteins being expressed in DAS-81419-2 soybean are not toxic or allergenic to humans (DAS, 2016). Nutritional Data Compositional analysis provided by the developer indicating the nutritional data of DAS-81419-2 in comparison with the non-transgenic soybean, range of commercial varieties and range of literature values (DAS, 2016). Results of the analysis indicated that there is no differences in the proximate, fiber, mineral, amino acid, fatty acid, vitamins, anti-nutrient and secondary metabolite levels of DAS-81419-2 and the non-transgenic soybean that can be considered biologically relevant. Conclusion For the transgenic DAS-81419-2 soybean, enough evidence is provided to support the equivalence of the genetically modified crop, in terms of the nutritional composition and food safety, with the conventional soybean other than the resistance to certain lepidopteran insects and glufosinate ammonium-containing herbicides. After reviewing the provided material of Dow AgroSciences, it is therefore concluded that DAS-81419-2 soybean is as safe as its conventional counterpart. BAI ASSESSMENT AND RECOMMENDATIONS Based on the documents submitted by the applicant, BAI made the following assessment: A. Host Organism Soybean contains key nutrients such as proteins, amino acids, fatty acids soybean. It also contains vitamins K, E, among others. It also contains anti-nutrients, such as trypsin/protease inhibitors, lectins, phytic acid especially wherein at its raw state; the use is limited for human and animal consumption. No (OECD, 2012) soybean is not a source of toxicants but it may cause IgE-mediated food allergies (OECD, 2012). It is also used as food and feed but soybean must be processed before use due to anti-nutrients (OECD, 2012). Based on WHO 97.5th percentile consumption of soybean, intake by general population is about 3.03 g/kg body weight and intake by children under 6 is about 5.55 g/kg bodyweight. B. Transgenic Plant DAS-81419-2 soybean is as safe and as nutritious as conventional soybean. There is no need to change consumption pattern as a result of introduction of this soybean event. It is approved in US (FDA, 2014), Canada (Health Canada, 2014), Australia & New Zealand (FSANZ, 2014), Argentina (SENASA, 2016), Brazil (CTNBio, 2016), Colombia (INVIMA, 2016), Japan (MHLW, 2014), Korea (MFDS, 2016), Mexico (COFEPRIS, 2015), South Africa (DAFF, 2016), Taiwan (DOH, 2015). C. Donor Organism Cry1Ac, Cry1F, and PAT proteins have a long history of safe use. The proteins are not known to possess potential pathogenic or allergenic properties. The introduced expressible sequences include Cry1Ac and Cry1F proteins conferring resistance to certain soybean insect pests and PAT protein conferring tolerance to glufosinate. PAT is used as a selectable marker during DAS- 81419-2 soybean development. Bacillus thuringiensis is a donor of Cry1Ac and Cry1F proteins. Streptomyces viridochromogenes is a donor of PAT. Donor organisms of genetic elements including promoters, terminators and border sequences include Arabidopsis thaliana, Agrobacterium tumefaciens, and Cassava vein mosaic virus. There are no publications concerning toxicity or allergenicity of these genetic elements in peer-reviewed journals. Three proteins are introduced and expressed in DAS-81419-2 soybean, including Cry1Ac, Cry1F, and PAT. The three proteins are present in a number of biotech crops cultivated for commercial use and have a long history of safe use. The proteins have specific modes of action and have no significant sequence similarity to known allergens or toxins. D. Transformation System DAS-81419-2 soybean was created via Agrobacterium-mediated transformation. Details of the transformation method are described adequately. The transformation protocol is described in detail as well as all the genetic components used. The genetic modification was intended to express Cry1Ac, Cry1F, and PAT in soybean plants, which provides protection against several soybean insect pests and tolerance to glufosinate. PAT was used as a selectable marker during DAS- 81419-2 soybean development. No carrier DNA was used for the transformation of pDAB9582 into soybean Glycine max. The Agrobacterium tumefaciens strain EHA101 carries the helper plasmid, pTiBo542. EHA101 was generated by inactivation of the T- DNA onc genes in strain A281 (Hood et al., 1986). E. Inserted DNA DAS-81419-2 soybean contains one intact copy of the T-DNA insert at a single locus. Insert copy number was demonstrated by Southern blot analysis. Southern blot results showed that the soybean event carries one intact copy of the T- DNA insert at a single locus. Integrity and order of genetic elements in DAS-81419-2 soybean were also demonstrated through Southern blot analysis. The T-DNA insert in DAS-81419-2 soybean contains a single, intact copy of each of the expression cassettes for the cry1Fv3, cry1Ac (synpro), and pat genes. There is a minor (<100 bp) fragment of the cry1Ac(synpro) gene identified at the 5′ end of the T-DNA insert; in addition, there is a minor 57-bp deletion at the site of T-DNA insertion. These sequence features were confirmed by the analysis of the T-DNA insert sequence, border sequence, and parental locus sequence. The T-DNA insert sequence, border sequence, and parental locus sequence were searched for potential putative reading frames using highly conservative criteria. All putative reading frames (stop to stop, greater than 8 amino acids) were then searched against databases for sequence similarity to known allergens or protein toxins. Bioinformatics analysis results showed that putative reading frames did not have sequence similarity with known allergens and toxins. No plasmid vector backbone sequence is present in DAS-81419-2 soybean as demonstrated by Southern blot analysis. Confirmation of lack of vector backbone using Southern blot analysis is a scientifically proven method and is sufficient. Cry1Ac, Cry1F, and PAT have a long history of safe use. The safety of the Cry1Ac and Cry1F proteins has been demonstrated in sprayable Bt formulations for pest control in agriculture for over half a century (Mendelsohn et al., 2003; EPA, 2011; Sanahuja et al., 2011). Both proteins are expressed in Dow AgroSciences’ WideStrike cotton authorized for cultivation, food and feed use. Bt corn and Bt cotton expressing variations of either Cry1Ac or Cry1F have been cultivated for commercial use in the U.S. and other countries for more than a decade. The PAT protein is present in several biotech crops approved for commercial cultivation, including corn, soybean, cotton, canola, rice, and sugar beets. F. Genetic Stability Stability of the T-DNA insert across five generations was demonstrated by Southern blot analysis. Segregation was assessed using both bioassay and event-specific PCR. One population of F2 and three populations of BC1F2 were assessed. Segregation result is consistent with the reported one copy T-DNA insert G. Expressed Material Expression levels of Cry1Ac, Cry1F, and PAT proteins were determined using protein-specific ELISA methods. Cry1Ac levels in roots, V5 leaf, V10-12 leaf, and grain were 0.39, 25.44, 23.16, and 1.04 ng/mg dry weight tissue. Cry1F levels in roots, V5 leaf, V10-12 leaf, and grain were 5.23, 56.75, 39.07, and 13.80 ng/mg dry weight tissue. The PAT protein levels in roots, V5 leaf, V10-12 leaf, and grain were 0.63, 5.23, 5.60, and 0.86 ng/mg dry weight tissue. Protein expression in pollen was not assessed due to low levels of protein, indicating low level of potential exposure, and scarcity of pollen material. Cry1Ac, Cry1F, and PAT have specific modes of action. The proteins do not play a role in endogenous plant metabolism. H. Toxicological Assessment Assuming that microbial Cry1Ac protein is equivalent to Cry1Ac expressed in DAS-81419-2 soybean, the digestibility of the Cry1Ac protein, in DAS-81419-2 soybean, was tested in vitro using simulated gastric fluid (SGF) pepsin. The estimated T50 of Cry1Ac is approximately less than 1 minute. The results showed that the Cry1Ac protein was readily degraded within 1 minute with no large size fragments remaining in SGF. Molecular mass of the CrylAc was significantly reduced by approximately 68% after heat treatment for 60 min at 91 ± 2°C in phosphate buffer meaning Cry1Ac protein is immunochemically denatured when heated. The Cry1Ac protein lost greater than 99% of its immunoreactivity, with results showing that it was almost undetectable by ELISA after exposure to the heat treatment. The Cry1Ac protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans or animals as per results of Bioinformatics analysis. Its acute toxicity via oral gavage was assessed. No Observable Effect Limit was not provided, but the acute oral LD50 of Cry1Ac microbial protein in male and female CD-l mice was greater than 700 mg/kg. The Cry1Ac protein was produced in Pseudomonas fluorescens. Characterization studies were performed to confirm the equivalency of the Cry1Ac protein expressed in DAS-81419-2 soybean with the P. fluorescens-derived Cry1Ac protein. The digestibility of the microbial Cry1F protein, was tested in vitro using simulated gastric fluid (SGF). The Cry1F protein (0.074 mM) was incubated in SGF (0.3% w/v pepsin at pH 1.2; US Pharmacopeia) at 37oC for various periods of time. The estimated T50 of Cry1F is approximately less than 1 minute. The results showed that the Cry1F protein was readily digested (not detectable at 1 minute) in SGF Molecular mass of the Cry1F was significantly reduced by approximately 61% after heat treatment for 60 min at 91 ± 2°C in phosphate buffer meaning Cry1F protein is immunochemically denatured when heated. The Cry1F protein lost more than 98% of its immunoreactivity, with results showing that it was almost undetectable by ELISA after exposure to the heat treatment. Using polyclonal antibody sandwich ELISA. The Cry1F protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans or animals as per result of Bioinformatics Analysis. Cry1F protein acute toxicity via oral gavage was assessed. No Observable Effect Limit was not provided, but the acute oral LD50 of Cry1F microbial protein in male and female CD-I mice was greater than 600 mg/kg. The Cry1F protein was produced in Pseudomonas fluorescens. Characterization studies were performed to confirm the equivalency of the Cry1F protein expressed in DAS-81419-2 soybean with the P. fluorescens-derived Cry1F protein. PAT protein is hydrolyzed rapidly in simulated gastric fluid containing pepsin. There was no evidence of acute toxicity in mice at a dose of 5000 mg/kg body weight of PAT protein. The PAT protein does not share any biologically meaningful amino acid sequence similarities with known toxic proteins that are harmful to humans or animals. Characterization of the biochemical properties of the plant-derived PAT protein was accomplished through the use of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), western blot analysis, protein sequence alignment, and lateral flow test strip assay. Using these methods, the PAT protein produced in DAS-81419-2 soybean was shown to be substantially equivalent to that produced in E. coli. I. Allergenicity Assessment The Cry1Ac, Cry1F and PAT proteins does not share any biologically meaningful amino acid sequence similarities with known allergenic proteins that are harmful to humans or animals as per results of Bioinformatics analysis.The total Cry1Ac, Cry1F and PAT protein percentage in food is less than 0.01%. Serum screening was not performed for all three proteins since all three has a long history of safe use and there is no evidence of allergenicity. J. Nutritional Data Nutrient composition analysis showed that DAS-81419-2 soybean is substantially equivalent to commercial varieties, the non- transgenic soybean, with no significant and biologically meaningful differences. No differences were observed between DAS-81419-2 soybean and comparator. Anti nutrients analysis showed DAS-81419-2 soybean is substantially equivalent to commercial varieties , the non-transgenic soybean. DAS-81419-2 soybean will undergo the same processing as conventional soybean. Effect on the level of antinutrients in DAS-81419-2 soybean would be no different from that on the level of antinutrients in conventional soybean. DAS-81419-2 soybean will undergo the same processing as conventional soybean. Effect on the level of antinutrients in DAS-81419-2 soybean would be no different from that on the level of antinutrients in conventional soybean. K. Recommendation Find scientific evidence that the regulated article applied for animal feed use is as safe as its conventional counterpart and shall not pose any significant risk to human and animal health
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date) May 6, 2024
E-mail:
Organization/agency name (Full name):
Bureau of Plant Industry
Contact person name:
Geronima P. Eusebio
Website:
Physical full address:
San Andres St., Malate, Manila
Phone number:
632 404 0409 loc 203
Fax number:
Country introduction:

In 1987, scientists from the University of the Philippines Los Banos (UPLB) and the International Rice Research Institute (IRRI), the Quarantine Officer of the Bureau of Plant Industry (BPI), and the Director for Crops of the Philippine Council for Agriculture, Forestry and Natural Resources Research and Development (PCARRD), recognizing the potential harm of the introduction of exotic species and genetic engineering, formed a committee and formulated the biosafety protocols and guidelines for genetic engineering and related research activities for UPLB and IRRI researchers. The committee went on to draft a Philippine biosafety policy, which was submitted to the Office of the President. On October 15, 1990, recognizing the potential for modern biotechnology both in improving the lives of the people and in creating hazards if not handled properly, President Corazon C. Aquino issued Executive Order 430 creating the National Committee on Biosafety of the Philippines (NCBP) that will formulate, review and amend national policy on biosafety and formulate guidelines on the conduct of activities on genetic engineering. The NCBP is comprised of representative of the Departments of Agriculture (DA); Environment and Natural Resources (DENR); Health (DOH); and Science and Technology (DOST), 4 scientists in biology, environmental science, social science and physical science; and 2 respected members of the community. On July 16, 2001, President Gloria Macapagal-Arroyo issued the Policy Statement on Modern Biotechnology, reiterating the government policy on promoting the safe and responsible use of modern biotechnology. On April 3, 2002, Department of Agriculture Administrative Order No. 8, Series of 2002 was issued implementing the guidelines for importation and release into the environment of Plants and Plant Products Derived from the Use of Modern Biotechnology. On March 17, 2006, President Gloria Macapagal-Arroyo issued Executive Order No.514 Establishing the National Biosafety Framework, prescribing guidelines for its implementation, reorganizing the National Committee on Biosafety of the Philippines, and for other purposes. On December 8, 2015, the Philippine Supreme Court declared DA AO8 null and void and any application for contained use, field testing, propagation and commercialization, and importation of GMOs was temporarily enjoined. In response to the nullification of DA AO8, the Technical Working Group composed of representatives from the Departments of Agriculture (DA), Science and Technology (DOST), Environment and Natural Resources (DENR), Health (DOH), and Interior and Local Government (DILG) drafted the Joint Department Circular No. 1, Series of 2016 (JDC No.1, S2016) titled 'Rules and Regulations for the Research and Development, Handling and Use, Transboundary Movement, Release into the Environment, and Management of Genetically-Modified Plant and Plant Products Derived from the Use of Modern Biotechnology'. There were series of meeting and five public consultations conducted before the JDC No.1, S2016 was approved and signed by the Secretaries of the abovementioned agencies on March 7, 2016 and took effect on April 15, 2016. Under this Circular, more government agencies were involved such as the Department of Science and Technology (DOST) to regulate applications for contained use and confined test of regulated articles; Department of Agriculture (DA) to evaluate applications for field trial, commercial propagation and transboundary movement of regulated articles; Department of Environment and Natural Resources (DENR) to evaluate environmental risks and impacts of regulated articles; Department of Health (DOH) to evaluate of environmental health impacts of regulated articles; and Department of the Interior and Local Government (DILG) to supervise public consultation during field trial.

 

Useful links
Relevant documents
Stacked events:

Gene stacking in plants can be conferred either through genetic engineering or conventional breeding A full risk assessment as to food and feed or for processing shall be conducted to plant products carrying stacked genes conferred through genetic engineering or conventional breeding, where the individual traits have no prior approval for direct use as food and feed or processing from the Bureau of Plant Industry (BPI) A desktop or documentary risk assessment on the possible or expected interactions between the genes shall be conducted for stacked gene products with multiple traits conferred through conventional breeding and individual events granted prior approval by the Bureau of Plant Industry.

 

Plant Products Carrying Stacked Genes Conferred Through (a) Genetic Engineering or b) Conventional Breeding, with Individual Traits That Have No Prior Approval:

A full risk assessnent as to  food and feed or processing shall be conducted,consistent with Part V of AO No. 8,"Approval Process For the Importation of Regulated Articles for Direct Use as Food and Feed or For Processing for plant products with multiple traits conferred through:

(a) genetic engineering, or

(b) conventional breeding, where the individual traits have no prior approval from the Bureau of Plant Industry (BPI) for direct use as food and feed or processing.

Plant Products Carrying Stacked Genes Conferred through Conventional Breeding:

For plant products with multiple traits conferred through conventional breeding,with all individual events granted prior approval and included in the Approval Registry, a notlfication shall be submitted by the technology developer to the BPI, which shall conduct an evaluation in accordance with the relevant criteria in Annex I of this Memorandum Circular. The list of data contained in Annex I will not preclude the inclusion of other issues and concerns that will be raised by the BPI and the Scientific and Technical Review Panel (STRP) during the course of the desktop review.

Notificatlon Requirement for Plant Products Carrying Stacked Genes

All technology developers shall submit a notification to the Bureau of Plant Industry of their developed plant products carrying stacked genes and shall be required to comply with the relevant approval process listed above.

The Bureau of Plant Industry shall issue a certiflcate as to the approval of the stacked gene product and shall likewise include the transformation event in the official approval registry of plant products for food and feed or processing.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Bureau of Plant Industry 692 San Andres St, Malate, Manila 1004

Republic of Korea
Name of product applicant: Dow AgroSciences Int'l. Ltd.
Summary of application:

Glufosinate herbicide tolerance, Lepidopteran insect resistance

Upload:
Date of authorization: 06/04/2016
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Please see the link below(in Korean).
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministry of Food and Drug Safety
Contact person name:
Website:
Physical full address:
Osong Health Technology Administration Complex, 187, Osongsaengmyeong 2-ro, Osong-eup, Cheongwon-gun, Chungcheonbuk-do, 363-700, Korea
Phone number:
82-43-719-2360
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Singapore
Name of product applicant: Dow AgroSciences
Summary of application:

Apply for use as food, feed and/or for processing 

Upload:
Date of authorization: 11/08/2020
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Soybean line DAS-81419-2 has been developed to protect against several lepidopteran pests of soybean. The line contains two insecticidal genes, cry1Ac(synpro) and cry1Fv3, derived from Bacillus thuringiensis. These genes express two insecticidal proteins Cry1Ac and Cry1F. DAS-81419-2 also contains a selectable marker gene (pat) from Streptomyces viridochromogenes, which expresses the enzyme phosphinothricin acetyltransferase (PAT) that detoxifies glufosinate ammonium herbicides. Molecular analyses of soybean line DAS-81419-2 indicate that it contains a single intact copy of each of the three cassettes cry1Fv3, cry1Ac(synpro) and pat together with a small partial fragment of cry1Ac(synpro) at the 5’ end of the insert. There has not been any disruption of endogenous genes as a result of the transformation procedure. The introduced genetic elements are stably inherited from one generation to the next. Soybean line DAS-81419-2 expresses three new proteins, Cry1Ac, Cry1F and PAT, which are non-toxic and non-allergenic to humans. Composition analyses did not indicate significance differences in the levels of constituents between the seed from soybean DAS-81419-2 and non-GM control. In an overall analysis, statistically significant differences were noted in a few constituents. However the differences were typically small, and all mean values were within both the reference range obtained for non-GM reference varieties grown at the same time and the literature range. Any observed differences are therefore considered to represent the natural variability that exists within soybean. Food derived from soybean line DAS-81419-2 is as safe as food derived from conventional soybean cultivars.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Agri-Food & Veterinary Authority of Singapore (AVA)
Contact person name:
Dr Wong Kwok Onn
Website:
Physical full address:
52 Jurong Gateway Road, #14-01, Singapore 608550
Phone number:
(65)68052895
Fax number:
Country introduction:

The Singapore Food Agency (SFA) is a Statutory Board established under the Ministry of Sustainability and the Environment (MSE) to oversee food safety and security. SFA’s mission is to ensure and secure a supply of safe food.  SFA adopts a risk-based approach to food safety. Foods with foodborne hazards that may pose potential food safety risks to consumers are subjected to more stringent checks, regardless of their country of origin. SFA has in place an integrated system to ensure that both imported and domestically produced foods are safe for consumption.  The system comprises control measures such as source accreditation, inspection and surveillance of food, laboratory analysis, food legislation and recall of food products, which safeguard food safety from farm to fork.

Useful links
Relevant documents
Stacked events:

More information on the guidelines for the safety assessment of stacked events can be found on GMAC’s website:

http://www.gmac.sg/Index_Singapore_Guidelines_on_the_Release_of_Agriculture_Related_GMOs.html

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Singapore Food Agency (SFA)

United States of America
Name of product applicant: Dow AgroSciences LLC
Summary of application:

Soybean
Trait 1 Added Protein or DNA: Cry1F
Source: Bacillus thuringiensissubsp. aizawai and subsp. berliner
Intended Effect: Resistance to lepidopteran insects
Trait 2 Added Protein or DNA: Cry1Ac
Source: Bacillus thuringiensissubsp. kurstaki and subsp. berliner
Intended Effect: Resistance to lepidopteran insects
Trait 3 Added Protein or DNA: Phosphinothricin N-acetyltransferase
Source: Streptomyces viridochromogenes
Intended Effect: Selectable Marker - tolerance to glufosinate-ammonium
Event Designation: DAS-81419-2

Upload:
Date of authorization: 30/01/2014
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Please consult the website links below.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: FDA's webpage regarding this variety
EPA Registered Plant Incorporated Protectants
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food and Drug Administration
Contact person name:
Jason Dietz
Website:
Physical full address:
5100 Paint Branch Parkway, College Park MD 20740
Phone number:
240-402-2282
Fax number:
Country introduction:

The United States is currently in the process of populating this database. The Food and Drug Administration regulates food and feed (food for humans and animals) from genetically engineered crops in conjunction with the Environmental Protection Agency (EPA). EPA regulates pesticides, including those that are plant incorporated protectants genetically engineered into food crops, to make sure that pesticide residues are safe for human and animal consumption and do not pose unreasonable risks of harm to human health or the environment. FDA In the Federal Register of May 29, 1992 (57 FR 22984), FDA published its "Statement of Policy: Foods Derived from New Plant Varieties" (the 1992 policy). The 1992 policy clarified the agency's interpretation of the application of the Federal Food, Drug, and Cosmetic Act with respect to human and animal foods derived from new plant varieties and provided guidance to industry on scientific and regulatory issues related to these foods. The 1992 policy applied to all foods derived from all new plant varieties, including varieties that are developed using genetic engineering (also known as recombinant deoxyribonucleic acid (rDNA) technology). In the 1992 policy, FDA recommended that developers consult with FDA about foods from genetically engineered plants under development and developers have routinely done so. In June 1996, FDA provided additional guidance to industry on procedures for these consultations (the consultation procedures). These procedures describe a process in which a developer who intends to commercialize food from a genetically engineered plant meets with the agency to identify and discuss relevant safety, nutritional, or other regulatory issues regarding the genetically engineered food and then submits to FDA a summary of its scientific and regulatory assessment of the food. FDA evaluates the submission and if FDA has questions about the summary provided, it requests clarification from the developer. At the conclusion of the consultation FDA responds to the developer by letter. The approach to the safety assessment of genetically engineered food recommended by FDA during consultations, including data and information evaluated, is consistent with that described in the Codex Alimentarius Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants. EPA The safe use of pesticidal substances is regulated by EPA. Food from a genetically engineered plant that is the subject of a consultation with FDA may contain an introduced pesticidal substance, also known as a plant-incorporated protectant (PIP), that is subject to food (food for humans and animals) safety and environmental review by EPA. PIPs are pesticidal substances produced by plants and the genetic material necessary for the plant to produce the substance. Both the PIP protein and its genetic material are regulated by EPA. When assessing the potential risks of PIPs, EPA requires studies examining numerous factors, such as risks to human health, non-target organisms and the environment, potential for gene flow, and insect resistance management plans, if needed. In regulating PIPs, decisions are based on scientific standards and input from academia, industry, other Federal agencies, and the public. Before the first PIP product was registered in 1995, EPA required that PIP products be thoroughly tested against human safety standards before they were used on human food and livestock feed crops. EPA scientists assessed a wide variety of potential effects associated with the use of PIPs, including toxicity, and allergenicity. These potential effects were evaluated in light of the public's potential exposures to these pesticides, taking into account all potential combined sources of the exposure (food, drinking water, etc.) to determine the likelihood that a person exposed at these levels would be predisposed to a health risk. Based on its reviews of the scientific studies and often peer reviews by the Federal Insecticide, Fungicide and Rodenticide Scientific Advisory Panel, EPA determined that these genetically engineered PIP products, when used in accordance with approved label directions and use restrictions, would not pose unreasonable risk to human health and the environment during their time-limited registration.

Useful links
Relevant documents
Stacked events:

Stacked events that are each plant incorporated protectants, as defined by the Environmental Protection Agency, must be registered by the Envriornmental Protection Agency before they can be commercialized.  Food/feed safety asssessment of single events are generally sufficient to ensure the safety of food/feed from stacked events.   

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food and Drug Administration ([email protected]); Environmental Protection Agency